Pomalidomide
Pomalidomide is a medication used to treat certain types of cancer, particularly multiple myeloma. It belongs to a class of drugs known as immunomodulatory agents.Pomalidomide is indicated for the treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
The dosage of Pomalidomide may vary depending on factors such as the patient's weight, overall health, and other medications being taken. It is typically taken orally once daily with water, with or without food.
Pomalidomide is contraindicated in pregnant women due to its potential to cause birth defects. It should not be used in patients with severe liver or kidney impairment.
Patients taking Pomalidomide should be closely monitored for signs of blood disorders, infections, and other adverse reactions. It is important to use effective contraception to prevent pregnancy while taking Pomalidomide.
Common side effects of Pomalidomide may include fatigue, nausea, diarrhea, constipation, and low blood cell counts. Serious side effects such as blood clots and severe skin reactions are possible but rare.
Pomalidomide may interact with certain medications, including strong CYP1A2 inhibitors and inducers, which may affect its efficacy or increase the risk of adverse reactions. Patients should inform their healthcare provider about all medications they are taking before starting Pomalidomide.
